Our study, according to the scientific literature, indicates that GnRH-a treatment may lead to an increase in BMI, especially in children with CPP who have a normal weight at the start of treatment, although the overall effect on the progression of obesity is minimal. This evidence concerns the gene GNRH1 and obesity disorder.